Rolofylline API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Rolofylline is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Rolofylline or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Rolofylline API 136199-02-5?

Description:
Here you will find a list of producers, manufacturers and distributors of Rolofylline. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Rolofylline 
Synonyms:
 
Cas Number:
136199-02-5 
DrugBank number:
DB12670 
Unique Ingredient Identifier:
7805S5HIHX

General Description:

Rolofylline, identified by CAS number 136199-02-5, is a notable compound with significant therapeutic applications. Rolofylline is under clinical development by pharmaceutical company NovaCardia for the treatment of congestive heart failure.

Mechanism of Action:

Rolofylline functions by: Rolofylline is an adenosine A1-receptor antagonist. Plasma adenosine levels are elevated in patients with heart failure and adenosine A1 receptors in the kidney mediate vasoconstriction of afferent arterioles, reabsorption of sodium and water in proximal tubules, and tubuloglomerular feedback in the juxtaglomerular apparatus. Accordingly, inhibition of these receptors would be expected to increase renal blood flow and enhance diuresis. The effects of Rolofylline on renal function are consistent with those obtained with another adenosine A1-receptor antagonist in both experimental and human heart failure. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.

Classification:

Rolofylline belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety, classified under the direct parent group Xanthines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Imidazopyrimidines class, specifically within the Purines and purine derivatives subclass.

Categories:

Rolofylline is categorized under the following therapeutic classes: Alkaloids, Diuretics, Heterocyclic Compounds, Fused-Ring, Natriuretic Agents, Purines, Purinones. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.